Evaluation of Levodopa for Parkinsonism. Levodopa (Dopar, Larodopa)
- PMID: 4396120
- DOI: 10.1001/jama.1971.03180250061016
Evaluation of Levodopa for Parkinsonism. Levodopa (Dopar, Larodopa)
Similar articles
-
The management of Parkinsonism.Practitioner. 1970 Apr;204(222):487-96. Practitioner. 1970. PMID: 4392664 No abstract available.
-
The treatment of parkinsonism. Current concepts.Med Clin North Am. 1972 Nov;56(6):1377-92. doi: 10.1016/s0025-7125(16)32327-6. Med Clin North Am. 1972. PMID: 4117524 Review. No abstract available.
-
Treatment of Parkinson's syndrome with L dihydroxyphenylalanine (levodopa).Ann Intern Med. 1970 Jan;72(1):29-35. doi: 10.7326/0003-4819-72-1-29. Ann Intern Med. 1970. PMID: 5410397 No abstract available.
-
Levodopa in Parkinsonism: potentiation of central effects with a peripheral inhibitor.N Engl J Med. 1972 Jan 6;286(1):8-14. doi: 10.1056/NEJM197201062860102. N Engl J Med. 1972. PMID: 4550085 Clinical Trial. No abstract available.
-
[Recent advances and pharmacological basis of the medical treatment of Parkinson's syndrome].Shinkei Kenkyu No Shimpo. 1971;15(4):992-1002. Shinkei Kenkyu No Shimpo. 1971. PMID: 4400830 Review. Japanese. No abstract available.
Cited by
-
Certain prediction on the effectiveness of L-DOPA on parkinsonism.Z Neurol. 1973 Feb 26;203(4):271-8. doi: 10.1007/BF00316184. Z Neurol. 1973. PMID: 4120793 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources